Next Post

New treatment option for schizophrenia Reagila(R) listed on PBS

Sen Sep 6 , 2021
MELBOURNE, Sep 6, 2021 – (ACN Newswire via – A new treatment for schizophrenia in adults, Reagila(R) (cariprazine), was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 September, providing patients with an additional treatment option. Approved in the US since 2015 and EU since 2017, Reagila is approved […]